Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
BackgroundPatients' experience of symptoms often goes undetected during consultation in an outpatient clinic, and the use of a patient-reported outcome measure (PRO) in such a setting could be useful to aid treatment decision-making. A new PRO measure, the HM-PRO (Hematological Malignancy Speci...
Saved in:
Main Authors: | Pushpendra Goswami (Author), Esther N. Oliva (Author), Tatyana Ionova (Author), Roger Else (Author), Jonathan Kell (Author), Adele K. Fielding (Author), Daniel M. Jennings (Author), Marina Karakantza (Author), Saad Al-Ismail (Author), Graham P. Collins (Author), Stewart McConnell (Author), Catherine Langton (Author), Magda J. Al-Obaidi (Author), Metod Oblak (Author), Sam Salek (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
by: Pushpendra Goswami, et al.
Published: (2020) -
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
by: Pushpendra Goswami, et al.
Published: (2020) -
ADEGAN KALIMAH LANGSUNGDINA NOVEL NGANTEURKEUNKARANGAN USEP ROMLI HM
by: Yuniarti, -
Published: (2007) -
PENGARUH PERPUTARAN PERSEDIAAN TERHADAPRENTABILITAS USAHA PADA PT. HM SAMPOERNA, TBK
by: Firmansyah Furdani, -
Published: (2009) -
Human milk sampling should be standardized if the adequacy of HM nutrients intake is assessed
by: Agnieszka Bzikowska‐Jura
Published: (2022)